keyword
https://read.qxmd.com/read/38654385/angiostrongylus-cantonensis-induces-energy-imbalance-and-dyskinesia-in-mice-by-reducing-the-expression-of-melanin-concentrating-hormone
#1
JOURNAL ARTICLE
Hui Huang, Zhongyuan Zhang, Mengdan Xing, Zihan Jin, Yue Hu, Minyu Zhou, Hang Wei, Yiwen Liang, Zhiyue Lv
BACKGROUND: Infection with Angiostrongylus cantonensis (AC) in humans or mice can lead to severe eosinophilic meningitis or encephalitis, resulting in various neurological impairments. Developing effective neuroprotective drugs to improve the quality of life in affected individuals is critical. METHODS: We conducted a Gene Ontology enrichment analysis on microarray gene expression (GSE159486) in the brains of AC-infected mice. The expression levels of melanin-concentrating hormone (MCH) were confirmed through real-time quantitative PCR (RT-qPCR) and immunofluorescence...
April 23, 2024: Parasites & Vectors
https://read.qxmd.com/read/38653485/fundamentals-of-deep-brain-stimulation-for-parkinson-s-disease-in-clinical-practice-part-1
#2
REVIEW
Camila Henriques de Aquino, Mariana Moscovich, Murilo Martinez Marinho, Lorena Broseghini Barcelos, André C Felício, Matthew Halverson, Clement Hamani, Henrique Ballalai Ferraz, Renato Puppi Munhoz
Deep brain stimulation (DBS) is recognized as an established therapy for Parkinson's disease (PD) and other movement disorders in the light of the developments seen over the past three decades. Long-term efficacy is established for PD with documented improvement in the cardinal motor symptoms of PD and levodopa-induced complications, such as motor fluctuations and dyskinesias. Timing of patient selection is crucial to obtain optimal benefits from DBS therapy, before PD complications become irreversible. The objective of this first part review is to examine the fundamental concepts of DBS for PD in clinical practice, discussing the historical aspects, patient selection, potential effects of DBS on motor and non-motor symptoms, and the practical management of patients after surgery...
April 2024: Arquivos de Neuro-psiquiatria
https://read.qxmd.com/read/38650913/do-causes-influence-functional-aspects-and-quality-of-life-in-patients-with-nonfibrocystic-bronchiectasis
#3
JOURNAL ARTICLE
Ádria Cristina da Silva, Jessica de Campos Medeiros, Monica Corso Pereira
BACKGROUND: The denomination of noncystic fibrosis bronchiectasis (NCFB) includes several causes, and differences may be expected between the patient subgroups regarding age, comorbidities, and clinical and functional evolution. This study sought to identify the main causes of NCFB in a cohort of stable adult patients and to investigate whether such conditions would be different in their clinical, functional, and quality of life aspects. METHODS: Between 2017 and 2019, all active patients with NCFB were prospectively evaluated searching for clinical data, past medical history, dyspnea severity grading, quality of life data, microbiological profile, and lung function (spirometry and six-minute walk test)...
2024: Pulmonary Medicine
https://read.qxmd.com/read/38649328/lrrk2-g2019s-impact-on-parkinson-disease-clinical-phenotype-and-treatment-in-tunisian-patients
#4
JOURNAL ARTICLE
Guedi Ali Barreh, Ikram Sghaier, Youssef Abida, Alya Gharbi, Amina Nasri, Saloua Mrabet, Amira Souissi, Mouna Ben Djebara, Sameh Trabelsi, Imen Kacem, Amina Gargouri-Berrachi, Riadh Gouider
BACKGROUND: LRRK2-G2019S is the most frequent mutation in North African Parkinson's disease (PD) patients.Data on its impact on disease progression and treatment response remains elusive.Therefore, we aimed to explore the clinical features,treatments,and complications through the disease course of PD Tunisian patients according to their LRRK2-G2019S profile. METHODS: Longitudinal retrospective study conducted in the department of Neurology,Razi University Hospital...
April 23, 2024: Journal of Movement Disorders
https://read.qxmd.com/read/38644623/long-term-follow-up-of-the-leap-study-early-versus-delayed-levodopa-in-early-parkinson-s-disease
#5
JOURNAL ARTICLE
Henrieke L Frequin, Constant V M Verschuur, Sven R Suwijn, Judith A Boel, Bart Post, Bastiaan R Bloem, Johannes J van Hilten, Teus van Laar, Gerrit Tissingh, Alexander G Munts, Joke M Dijk, Anthony E Lang, Marcel G W Dijkgraaf, Jeroen Hoogland, Rob M A de Bie
BACKGROUND AND OBJECTIVE: The Levodopa in EArly Parkinson's disease study showed no effect of earlier versus later levodopa initiation on Parkinson's disease (PD) progression over 80 weeks. We now report the effects over 5 years. METHODS: The Levodopa in EArly Parkinson's disease study randomly assigned patients to levodopa/carbidopa 300/75 mg daily for 80 weeks (early start) or to placebo for 40 weeks followed by levodopa/carbidopa 300/75 mg daily for 40 weeks (delayed start)...
April 21, 2024: Movement Disorders: Official Journal of the Movement Disorder Society
https://read.qxmd.com/read/38642669/angiotensin-converting-enzyme-inhibition-prevents-l-dopa-induced-dyskinesia-in-a-6-ohda-induced-mouse-model-of-parkinson-s-disease
#6
JOURNAL ARTICLE
Hye-Yeon Park, Ga Seul Lee, Jun Go, Young-Kyoung Ryu, Chul-Ho Lee, Jeong Hee Moon, Kyoung-Shim Kim
Parkinson's disease (PD) is characterised by severe movement defects and the degeneration of dopaminergic neurones in the midbrain. The symptoms of PD can be managed with dopamine replacement therapy using L-3, 4-dihydroxyphenylalanine (L-dopa), which is the gold standard therapy for PD. However, long-term treatment with L-dopa can lead to motor complications. The central renin-angiotensin system (RAS) is associated with the development of neurodegenerative diseases in the brain. However, the role of the RAS in dopamine replacement therapy for PD remains unclear...
April 18, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38641957/mining-and-analysis-of-security-alert-signals-of-valbenazine-based-on-the-food-and-drug-administration-adverse-event-reporting-system-database
#7
JOURNAL ARTICLE
Qi Wang, Kankan Qu, Zhiqiang Du, Yuan Shen, Ying Jiang, Haohao Zhu
BACKGROUND: Valbenazine is used for tardive movement disorders in adults. Current studies on its safety are mostly from clinical trials and small case reports, limiting information on rare adverse reactions. This study investigated valbenazine-related adverse event (AE) risk signals using the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database. METHODS: Valbenazine AEs data were collected from the FAERS database from 2017 Q2 to 2023 Q1, employing methods like reporting odds ratio (ROR), proportional reporting ratio (PRR), Bayesian confidence propagation neural network, and empirical Bayesian geometric mean...
April 20, 2024: Journal of Psychopharmacology
https://read.qxmd.com/read/38640851/the-association-between-alterations-in-motor-and-cognitive-dimensions-of-schizophrenia-spectrum-disorders-a-systematic-review
#8
REVIEW
Bernardo Melo Moura, Luís Madeira, P Roberto Bakker, Peter van Harten, Machteld Marcelis
Motor and cognitive alterations in schizophrenia-spectrum disorders (SSD) share common neural underpinnings, highlighting the necessity for a thorough exploration of the connections between these areas. This relationship is crucial, as it holds potential significance in unraveling the underlying mechanisms of SSD pathophysiology, ultimately leading to advancements in clinical staging and treatment strategies. The purpose of this review was to characterize the relationship between different hyper and hypokinetic domains of motor alterations and cognition in SSD...
April 18, 2024: Schizophrenia Research
https://read.qxmd.com/read/38635862/structural-lung-disease-and-clinical-phenotype-in-bronchiectasis-patients-the-embarc-ct-study
#9
JOURNAL ARTICLE
Angelina L P Pieters, Tjeerd van der Veer, Jennifer J Meerburg, Eleni-Rosalina Andrinopoulou, Menno M Vd Eerden, Pierluigi Ciet, Stefano Aliberti, Pierre-Regis Burgel, Megan L Crichton, Amelia Shoemark, Pieter C Goeminne, Michal Shteinberg, Michael R Loebinger, Charles S Haworth, Francesco Blasi, Harm Awm Tiddens, Daan Caudri, James D Chalmers
RATIONALE: Chest computed tomography -scans (CTs) are essential to diagnose and monitor bronchiectasis (BE). To date, little quantitative data is available about the nature and extent of structural lung abnormalities (SLA) on CTs of BE patients. OBJECTIVES: to investigate SLA on CTs of patients with bronchiectasis and the relationship of SLAs to clinical features using the European Bronchiectasis Registry (EMBARC) Methods: CTs from BE patients included in the EMBARC registry were analyzed using the validated Bronchiectasis Scoring Technique for CT (BEST-CT)...
April 18, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38635129/clinical-features-cerebrospinal-fluid-changes-and-prognosis-in-chinese-patients-with-autoimmune-encephalitis
#10
JOURNAL ARTICLE
Wu Yan, Wang Mengke, Su Zhiqiang, Gu Jiaao, Guan Fulin
INTRODUCTION: Autoimmune encephalitis (AE) is a rare, treatable disease of the central nervous system (CNS) caused by an antibody-related immune response. This study is to investigate the correlation of clinical features, cerebrospinal fluid (CSF) characteristics, and prognosis in patients with AE. METHODS: A total of 71 patients diagnosed with antibody-positive AE were retrospectively analyzed. The patients were divided into three groups: anti-NMDAR group, anti-LGI1 group, and other types...
April 18, 2024: Acta Neurologica Belgica
https://read.qxmd.com/read/38635103/preoperative-diagnosis-and-safe-surgical-approach-in-gallbladder-amyloidosis-a-case-report
#11
JOURNAL ARTICLE
Makoto Shinohara, Masakazu Hashimoto, Yoshihito Kitamura, Keigo Nakashima, Michinori Hamaoka, Masashi Miguchi, Toshihiro Misumi, Nobuaki Fujikuni, Satoshi Ikeda, Yasuhiro Matsugu, Yui Hattori, Takashi Nishisaka, Hideki Nakahara
BACKGROUND: Preoperative diagnosis of gallbladder amyloidosis is usually difficult. In our case, the patient exhibited gallbladder dyskinesia, which led us to suspect cholecystic amyloidosis. We were able to safely perform surgery before cholecystitis onset. CASE PRESENTATION: A 59-year-old male patient with a history of multiple myeloma and cardiac amyloidosis presented to our hospital with a chief complaint of epicardial pain. Abdominal ultrasonography and computed tomography revealed an enlarged gallbladder and biliary sludge without any specific imaging findings of cholecystitis...
April 18, 2024: Surgical Case Reports
https://read.qxmd.com/read/38626355/recessively-inherited-deficiency-of-secreted-wfdc2-he4-causes-nasal-polyposis-and-bronchiectasis
#12
JOURNAL ARTICLE
Gerard W Dougherty, Lawrence E Ostrowski, Tabea Nöthe-Menchen, Johanna Raidt, Andre Schramm, Heike Olbrich, Weining Yin, Patrick R Sears, Hong Dang, Amanda J Smith, Achim G Beule, Rim Hjeij, Niels Rutjies, Eric G Haarman, Saskia M Maas, Thomas W Ferkol, Peadar G Noone, Kenneth N Olivier, Diana C Bracht, Pascal Barbry, Laure-Emmanuelle Zaragosi, Morgane Fierville, Sabine Kliesch, Kai Wohlgemuth, Julia König, Sebastian George, Niki T Loges, Agathe Ceppe, Matthew R Markovetz, Hong Luo, Ting Guo, Hoda Rizk, Tarek Eldesoky, Katrin Dahlke, Karsten Boldt, Marius Ueffing, David B Hill, Yuan-Ping Pang, Michael R Knowles, Maimoona A Zariwala, Heymut Omran
RATIONALE: Bronchiectasis is a pathological dilatation of the bronchi in the respiratory airways associated with environmental or genetic causes (e.g., cystic fibrosis, primary ciliary dyskinesia and primary immunodeficiency disorders), but most cases remain idiopathic. OBJECTIVES: To identify novel genetic defects in unsolved cases of bronchiectasis presenting with severe rhinosinusitis, nasal polyposis, and pulmonary Pseudomonas aeruginosa infection. METHODS: DNA was analyzed by next-generation or targeted Sanger sequencing...
April 16, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38612353/studies-of-a-naturally-occurring-selenium-induced-microcytic-anemia-in-the-przewalski-s-gazelle
#13
JOURNAL ARTICLE
Yang Ran, Yuanfeng Li, Xiaoyun Shen
Due to the fencing of the Przewalski's gazelle ( Procapra przewalskii ), the microcytic anemia incidence rate continues to increase. The primary pathological symptoms include emaciation, anemia, pica, inappetence, and dyskinesia. To investigate the cause of microcytic anemia ailment in the Przewalski's gazelle, the Upper Buha River Area with an excessive incidence was chosen as the experimental pasture, and the Bird Island Area without microcytic anemia disease was chosen as the control field. Then, the mineral contents in the soil, forage, blood, and liver, as well as the blood routine parameters and biochemical indexes were measured...
April 5, 2024: Animals: An Open Access Journal From MDPI
https://read.qxmd.com/read/38607006/advancing-primary-ciliary-dyskinesia-diagnosis-through-high-speed-video-microscopy-analysis
#14
JOURNAL ARTICLE
Wilfredo De Jesús-Rojas, Zachary J Demetriou, José Muñiz-Hernández, Gabriel Rosario-Ortiz, Frances M Quiñones, Marcos J Ramos-Benitez, Ricardo A Mosquera
Primary ciliary dyskinesia (PCD) is an inherited disorder that impairs motile cilia, essential for respiratory health, with a reported prevalence of 1 in 16,309 within Hispanic populations. Despite 70% of Puerto Rican patients having the RSPH4A [c.921+3_921+6del (intronic)] founder mutation, the characterization of the ciliary dysfunction remains unidentified due to the unavailability of advanced diagnostic modalities like High-Speed Video Microscopy Analysis (HSVA). Our study implemented HSVA for the first time on the island as a tool to better diagnose and characterize the RSPH4A [c...
March 24, 2024: Cells
https://read.qxmd.com/read/38605905/next-generation-sequencing-based-copy-number-variation-analysis-in-chinese-patients-with-primary-ciliary-dyskinesia-revealed-novel-dnah5-copy-number-variations
#15
JOURNAL ARTICLE
Weicheng Chen, Zhuoyao Guo, Mengru Li, Wei Sheng, Guoying Huang
UNLABELLED: Primary ciliary dyskinesia (PCD) is a rare disorder characterized by extensive genetic heterogeneity. However, in the genetic pathogenesis of PCD, copy number variation (CNV) has not received sufficient attention and has rarely been reported, especially in China. Next-generation sequencing (NGS) followed by targeted CNV analysis was used in patients highly suspected to have PCD with negative results in routine whole-exome sequencing (WES) analysis. Quantitative real-time polymerase chain reaction (qPCR) and Sanger sequencing were used to confirm these CNVs...
February 2024: Phenomics
https://read.qxmd.com/read/38605126/combined-approaches-including-long-read-sequencing-address-the-diagnostic-challenge-of-hydin-in-primary-ciliary-dyskinesia
#16
JOURNAL ARTICLE
Andrew Fleming, Miranda Galey, Lizi Briggs, Matthew Edwards, Claire Hogg, Shibu John, Sam Wilkinson, Ellie Quinn, Ranjit Rai, Tom Burgoyne, Andy Rogers, Mitali P Patel, Paul Griffin, Steven Muller, Siobhan B Carr, Michael R Loebinger, Jane S Lucas, Anand Shah, Ricardo Jose, Hannah M Mitchison, Amelia Shoemark, Danny E Miller, Deborah J Morris-Rosendahl
Primary ciliary dyskinesia (PCD), a disorder of the motile cilia, is now recognised as an underdiagnosed cause of bronchiectasis. Accurate PCD diagnosis comprises clinical assessment, analysis of cilia and the identification of biallelic variants in one of 50 known PCD-related genes, including HYDIN. HYDIN-related PCD is underdiagnosed due to the presence of a pseudogene, HYDIN2, with 98% sequence homology to HYDIN. This presents a significant challenge for Short-Read Next Generation Sequencing (SR-NGS) and analysis, and many diagnostic PCD gene panels do not include HYDIN...
April 11, 2024: European Journal of Human Genetics: EJHG
https://read.qxmd.com/read/38602513/genetic-spectrum-and-clinical-characteristics-of-patients-with-primary-ciliary-dyskinesia-a-belgian-single-center-study
#17
JOURNAL ARTICLE
Noelia Rodriguez Mier, Martine Jaspers, Evelien Van Hoof, Mark Jorissen, Natalie Lorent, Marijke Proesmans, François Vermeulen, Jeroen Breckpot, Mieke Boon
PURPOSE: We aimed to examine the correlation between clinical characteristics and the pathogenic gene variants in patients with Primary Ciliary Dyskinesia (PCD). METHODS: We conducted a retrospective single-center study in patients with PCD followed at the University Hospitals Leuven. We included patients with genetically confirmed PCD and described their genotype, data from ultrastructural ciliary evaluation and clinical characteristics. Genotype/phenotype correlations were studied in patients with the most frequently involved genes...
April 11, 2024: Lung
https://read.qxmd.com/read/38602420/glycine-and-clozapine-potential-relevance-for-the-treatment-of-parkinson-s-disease
#18
EDITORIAL
Shawn Maddaford, Philippe Huot
No abstract text is available yet for this article.
April 11, 2024: Neurodegenerative Disease Management
https://read.qxmd.com/read/38601835/clozapine-prescripers-dogmatic-or-pragmatic
#19
REVIEW
Ahmed Naguy, Hessa Alhazeem
Clozapine, amongst antipsychotics, has a unique composite mode of action that might translate into an expanded therapeutic potential on clinical grounds. Sorely, clozapine remains underutilized.
April 4, 2024: Psychopharmacology Bulletin
https://read.qxmd.com/read/38600683/neurological-perspectives-should-be-integrated-into-the-management-of-tardive-dyskinesia-expert-opinion-and-proposed-educational-initiatives-in-asia
#20
JOURNAL ARTICLE
Roongroj Bhidayasiri, Onanong Phokaewvarangkul, Thien Thien Lim, Pramod Kumar Pal, Hirohisa Watanabe, Jin Whan Cho, Hui-Fang Shang
No abstract text is available yet for this article.
April 11, 2024: Journal of Movement Disorders
keyword
keyword
14125
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.